Trademark Overview
On Monday, April 28, 2025, a trademark application was filed for SYMREPLIQ with the United States Patent and Trademark Office. The USPTO has given the SYMREPLIQ trademark a serial number of 99159217. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 28, 2025. This trademark is owned by Gamida Cell Inc.. The SYMREPLIQ trademark is filed in the Pharmaceutical Products category with the following description:
Cell therapy preparations for the treatment of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders